Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2011-04-19
2011-04-19
Zhou, Shubo (Joe) (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C435S006120, C530S387100, C702S020000
Reexamination Certificate
active
07930107
ABSTRACT:
The present invention relates to novel methods for generating variant proteins with increased host string content, and proteins that are engineered using these methods.
REFERENCES:
patent: 4943533 (1990-07-01), Mendolsohn
patent: 5530101 (1996-06-01), Queen
patent: 5585089 (1996-12-01), Queen
patent: 5693761 (1997-12-01), Queen
patent: 5693762 (1997-12-01), Queen
patent: 5712120 (1998-01-01), Rodriquez
patent: 5723323 (1998-03-01), Kauffman
patent: 5763192 (1998-06-01), Kauffman
patent: 5814476 (1998-09-01), Kauffman
patent: 5817483 (1998-10-01), Kauffman
patent: 5821337 (1998-10-01), Carter
patent: 5824514 (1998-10-01), Kauffman
patent: 5859205 (1999-01-01), Adair
patent: 6054297 (2000-04-01), Carter
patent: 6180370 (2001-01-01), Carter
patent: 6188965 (2001-02-01), Mayo et al.
patent: 6269312 (2001-07-01), Mayo
patent: 6352842 (2002-03-01), Short
patent: 6358709 (2002-03-01), Short
patent: 6361974 (2002-03-01), Short
patent: 6365377 (2002-04-01), Patton
patent: 6403312 (2002-06-01), Dahiyat
patent: 6407213 (2002-06-01), Carter
patent: 6708120 (2004-03-01), Mayo
patent: 6737056 (2004-05-01), Presta
patent: 6792356 (2004-09-01), Mayo
patent: 6804611 (2004-10-01), Mayo
patent: 6950754 (2005-09-01), Mayo
patent: 7231328 (2007-06-01), Desjarlais
patent: 2002/0048772 (2002-04-01), Dahiyat
patent: 2002/0090648 (2002-07-01), Dahiyat
patent: 2002/0119492 (2002-08-01), Chirino
patent: 2003/0022285 (2003-01-01), Chirino
patent: 2003/0049654 (2003-03-01), Dahiyat
patent: 2003/0130827 (2003-07-01), Bentzien et al.
patent: 2003/0153043 (2003-08-01), Carr et al.
patent: 2004/0002587 (2004-01-01), Watkins
patent: 2004/0043429 (2004-03-01), Dahiyat
patent: 2004/0043430 (2004-03-01), Dahiyat
patent: 2004/0132101 (2004-07-01), Lazar
patent: 2005/0038610 (2005-02-01), Mayo
patent: 2005/0054832 (2005-03-01), Lazar
patent: 2005/0064555 (2005-03-01), Marshall
patent: 2005/0143929 (2005-06-01), Desjarlais
patent: 2005/0244403 (2005-11-01), Lazar
patent: 2006/0003412 (2006-01-01), Chamberlain et al.
patent: 2006/0121032 (2006-06-01), Dahiyat
patent: 2006/0134105 (2006-06-01), Lazar
patent: 2007/0166309 (2007-07-01), Lazar et al.
patent: 1 951 757 (2008-08-01), None
patent: 08/280387 (1996-10-01), None
patent: WO 96/40210 (1996-12-01), None
patent: WO 98/47089 (1998-10-01), None
patent: WO 98/52976 (1998-11-01), None
patent: WO 98/59244 (1998-12-01), None
patent: WO 00/23564 (2000-04-01), None
patent: WO 00/42561 (2000-07-01), None
patent: WO/0042072 (2000-07-01), None
patent: WO 01/21823 (2001-03-01), None
patent: WO 01/59066 (2001-08-01), None
patent: WO 01/70947 (2001-09-01), None
patent: WO 02/00165 (2002-01-01), None
patent: WO 02/22826 (2002-03-01), None
patent: WO 02/068453 (2002-09-01), None
patent: WO 02/068698 (2002-09-01), None
patent: WO 02/069232 (2002-09-01), None
patent: WO 02/77187 (2002-10-01), None
patent: WO 02/079232 (2002-10-01), None
patent: WO 03/000405 (2003-01-01), None
patent: WO 03/002607 (2003-01-01), None
patent: WO 03/014325 (2003-02-01), None
patent: WO 03/025154 (2003-03-01), None
patent: WO 03/043583 (2003-05-01), None
patent: WO 03/048321 (2003-06-01), None
patent: WO 03/059282 (2003-07-01), None
patent: WO 2004/029207 (2004-04-01), None
patent: WO 2004/029207 (2004-04-01), None
patent: WO 2004/063351 (2004-07-01), None
patent: WO 2004/074455 (2004-09-01), None
patent: WO 2005/056606 (2005-06-01), None
patent: WO 2005/056759 (2005-06-01), None
patent: WO2007/044616 (2007-04-01), None
U.S. Appl. No. 11/488,984, filed Jul. 18, 2006, Desjarlais.
U.S. Appl. No. 10/339,788, filed Jan. 8, 2003, Chirino.
U.S. Appl. No. 60/222,697, filed Aug. 2, 2000, Li.
Adenot et at., “Peptides quantitative stucture-function relationships: An automated mutation strategy to design peptides and pseudopeptides from substitutio matrices” 1999,J. Mol. Graph. Model. 17: 292-309.
Al-Lazikani et al., “Standard Conformations for the Canonical Structures of Immunoglobulins” 1997,J. Mol. Biol. 273: 927-948.
Amstutz et al., 2001, “In vitro display technologies: novel developments and applications”Curr Opin Biotechnol12:400-405.
Arnold et al:, “The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues” 2002,J Immunology169(2): 739-49.
Barbie & Lefranc, “The Human Immunoglobulin Kappa Variable (IGKV) Genes and Joining (IGKJ) Segments” 1998,Exp Clin Immunogenet15(3):171-83.
Benhar et al., “Highly Efficient Selection of Phage Antibodies Mediated by Display of Angigen as Lp-OmpA Fusions on Live Bacteria” 2000,J Mol Biol301:893-904.
Boder & Wittrup, “Yeast Surface display for screening combinatorial polypeptide libraries”1997,Nat Biotechnol15:553-557.
Boder & Wittrup, “Yeast Surface Display for Directed Evolution of Protein Expression, Affinity, and Stabiliy” 2000,Methods Enzymol328:430-44.
Bowen et al. “Functional Effects of CD30 on a Large Granular Lymphoma Cell Line YT”Journal of Immunology, 1993, 151: 5896.
Bowie & Sauer, “Identifying determinants of folding and activity for a protein of unknown structure” 1989,Proc. Nat. Acad. Sci. USA86: 2152-2156.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”1990,Science247: 1306-1310.
Bruggemann et al., 1997, “Production of human antibody repertoires in transgenic mice”Curr Opin Biotechnol8:455-458.
Canfield & Morrison, “The-Binding Affinity of Human IgG for its High Affinity Fc Receptor is Determined by Mulitpile Amino Acids in the Cg2 Domain and is Modulated by the Hinge Region” 1991, J. Exp. Med. 173: 1483-1491.
Chappel et al., “Identification of a Secondary FcγRI Binding-Site within a Genetically Engineered Human IgG Antobidy” 1993, Journal of Biological Chemistry 268:25124-25131.
Chappel et al., “Identification of the Fcγ receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies”1991, Proc. Natl. Acad. Sci. USA 88(20): 9036-9040.
Chen et al., 2001, “Isolation of high-affinity ligand-binding proteins by perplasmic expression with cytometric screening(PECS)”Nat Biotechnol19:537-542.
Chothia & Lesk, “Canonical Structures for the Hypervariable Regions of Immunoglobulins” 1987,J. Mol. Biol. 196:901-917.
Chothia, C. et al., “Conformations of immunoglobulin hypervariable regions”Nature342, 877-883 (1989).
Clark, “Antibody humanization: a case of the Emperor's new clothes?” 2000,Immunol Today21:397-402.
Coco et al., “DNA shuffling method for generating highly recombined genes and evolved enzymes” 2001,Nat Biotechnol19:354-359.
Cox et al. Eur J Immunol. “A directory of human germn-line Vxsegments reveals a strong bias in their usage” Apr. 1994:24(4):827-36.
Crameri et al., “DNA Shuffling of a family of genes from diverse species accelerates directed evolution” 1998,Nature391:288-291.
Davies et al., “Expression of GnTIII ina Recombinant Anti-CD20 CHO Production Cell Line: Expression of Antibodies with Altered Glycoforms Leads to an Increase In ADCC Through Higher Affinity for FcγRIII” 2001,Biotechnol Bioeng74:288-294.
Desjarlais & Berg, “Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins” 1993,Proc Natl Acad Sci USA90(6):2256-60.
Fields & Song, “A Novel Genetic System to Detect Protein-protein Interactions” 1989,Nature340:245-246.
Forsthuber et al., “T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4(DRB1*0401) Transgenic Mice are Encephalitogenic and are Presented by Human B Cells” 2001,J. Immunol. 167:119-125.
Georgiou et al., “Practical applications of engineering Gram-negative bacterial cell surfaces” 1993,Trends Biotechnol11:6-10.
Georgiou et al., “Display
Desjarlais John R.
Hammond Philip W.
Lazar Gregory Alan
Morgan & Lewis & Bockius, LLP
Silva, Esq. Robin M.
Xencor, Inc.
Zhou Shubo (Joe)
LandOfFree
Methods of generating variant proteins with increased host... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of generating variant proteins with increased host..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of generating variant proteins with increased host... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2737376